Suchergebnisse - "Nejat, Reza"

PubPharm (12)

1

S protein, ACE2 and Host Cell Proteases in SARS-CoV2 Cell Entry and Infectivity; Is Soluble ACE2 a Two Blade Sword?

enthalten in: Preprints.org | 2023

von Nejat, R. | Torshizi, M. | Najafi, D.

2

S Protein, ACE2 and Host Cell Proteases in SARS-CoV-2 Cell Entry and Infectivity; Is Soluble ACE2 a Two Blade Sword? A Narrative Review

enthalten in: Vaccines | 2023

von Nejat, R. | Torshizi, M. | Najafi, D.

3

GPCRs of Diverse Physiologic and Pathologic Effects with Fingerprints in COVID-19

enthalten in: Preprints.org | 2022

von Nejat, R. | Sadr, A. | Najafi, D.

4

Are Losartan and Imatinib Effective Against SARS-CoV2 Pathogenesis? a Pathophysiologic-Based in Silico Study

enthalten in: chemRxiv.org | 2021

von Nejat, R. | Sadr, A.

5

Losartan Inhibits SARS-CoV-2 Replication in Vitro

enthalten in: Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques | 2021

von Nejat, R. | Sadr, A. | Freitas, B. | +4

6

Are losartan and imatinib effective against SARS-CoV2 pathogenesis? A pathophysiologic-based in silico study

enthalten in: In silico pharmacology | 2021

von Nejat, R. | Sadr, A.

7

Losartan promotes cell survival following SARS-CoV-2 infection in vitro

enthalten in: bioRxiv.org | 2020

von Nejat, R. | Sadr, A. | Freitas, B. | +4

8

Are losartan and imatinib effective against SARS-CoV2 pathogenesis? A pathophysiologic-based in silico study

enthalten in: In Silico Pharmacology | 2020

von Nejat, R. | Sadr, A.

9

Are losartan and imatinib effective against SARS-CoV2 pathogenesis? A pathophysiologic-based in silico study

enthalten in: In Silico Pharmacology | 2020

von Nejat, R. | Sadr, A.

10

Daily Low Dose of Erythropoietin in Neuroinflammation; EPO Might Be Hazardous in COVID-19

enthalten in: Preprints.org | 2020

von Nejat, R. | Sadr, A. | Ebrahimi, A. | +2